|
- Guardant Health | Conquering Cancer With Data
Guardant Health is a leading precision medicine company focused on transforming patient care and conquering cancer with data
- Guardant Complete® for Early and Advanced Stage Cancer
Guardant Reveal is a completely tissue-free test that detects circulating tumor DNA (ctDNA) for minimal residual disease (MRD) assessment in early-stage colorectal, breast, and lung cancers
- For Patients - Guardant Health
At Guardant Health, we are dedicated to helping patients at all stages of cancer live longer and healthier lives through the power of our blood tests and the insights they unlock
- Shield™ for Cancer Screening - Guardant Health
Explore our FDA-approved Shield™ blood-based screening test Discover how our advanced technology detects cancer early, when it's most treatable
- Careers - Guardant Health
Get to know Guardant Health, our story, and our mission Learn how we are changing the future of cancer care See how our blood tests are providing insights that can help patients at all stages of the disease View all of our screening, early-stage cancer, and advanced cancer clinical studies
- Guardant Health
Email Password SIGN IN Forgot your password? New to Guardant? Register new account
- For Healthcare Providers - Guardant Health
Explore Guardant Health's integrated solutions for cancer care From diagnosis to treatment and management, we provide support for all stages of the disease
- Clinical Studies - Guardant Health
We have developed the first FDA-approved, Medicare-covered blood test to screen for colorectal cancer, the second leading cause of cancer-related death globally, and are continuing to study Guardant’s Shield test in screening for other cancer types, including lung cancer
|
|
|